Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard B Seeff

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|March 8, 2016
Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United StatesMark I Avigan, Robert P Mozersky, Leonard B Seeff
Antiviral Therapy|June 27, 2007
Complementary and alternative medicine (CAM) for the treatment of chronic hepatitis B and C: a reviewApurva A Modi, Elizabeth C Wright, Leonard B Seeff
Gastroenterology|December 16, 2014
Herbal products and the liver: a review of adverse effects and mechanismsLeonard B Seeff, Herbert L Bonkovsky, Victor J Navarro, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 2, 2003
Hepatitis C and renal disease: an updateCatherine M Meyers, Leonard B Seeff, Catherine O Stehman-Breen, et al.
Hepatology (Baltimore, Md.)|September 29, 2016
Liver injury from herbal and dietary supplementsVictor J Navarro, Ikhlas Khan, Einar Björnsson, et al.
Clinical Chemistry|February 26, 2003
Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infectionD Robert Dufour, Mageli Talastas, Maria D A Fernandez, et al.
Drug Safety|October 30, 2014
Causality assessment for suspected DILI during clinical phases of drug developmentArie Regev, Leonard B Seeff, Michael Merz, et al.
Journal of Clinical Gastroenterology|August 6, 2005
More severe parenchymal injury in chronic hepatitis C acquired by recent injection drug useMatthew M Yeh, Zelma J Buskell, Leonard B Seeff, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 casesAllen D Brinker, Ronald T Wassel, Jenna Lyndly, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trialMarc G Ghany, Hae-Young Kim, Anne Stoddard, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|March 8, 2016
Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United StatesMark I Avigan, Robert P Mozersky, Leonard B Seeff
Antiviral Therapy|June 27, 2007
Complementary and alternative medicine (CAM) for the treatment of chronic hepatitis B and C: a reviewApurva A Modi, Elizabeth C Wright, Leonard B Seeff
Gastroenterology|December 16, 2014
Herbal products and the liver: a review of adverse effects and mechanismsLeonard B Seeff, Herbert L Bonkovsky, Victor J Navarro, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 2, 2003
Hepatitis C and renal disease: an updateCatherine M Meyers, Leonard B Seeff, Catherine O Stehman-Breen, et al.
Hepatology (Baltimore, Md.)|September 29, 2016
Liver injury from herbal and dietary supplementsVictor J Navarro, Ikhlas Khan, Einar Björnsson, et al.
Clinical Chemistry|February 26, 2003
Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infectionD Robert Dufour, Mageli Talastas, Maria D A Fernandez, et al.
Drug Safety|October 30, 2014
Causality assessment for suspected DILI during clinical phases of drug developmentArie Regev, Leonard B Seeff, Michael Merz, et al.
Journal of Clinical Gastroenterology|August 6, 2005
More severe parenchymal injury in chronic hepatitis C acquired by recent injection drug useMatthew M Yeh, Zelma J Buskell, Leonard B Seeff, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 casesAllen D Brinker, Ronald T Wassel, Jenna Lyndly, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trialMarc G Ghany, Hae-Young Kim, Anne Stoddard, et al.
Pageof 5